Our data showing the opposite expression of STAT3 and p65-NFκB according to lesion grade in peripheral blood leukocytes led us to speculate whether these signaling pathways could be part of the immunomodulatory effects of cervical cancer. The gene discussed is NFKB1; the disease is cervical cancer.